Your browser doesn't support javascript.
loading
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Abu-Raddad, Laith J; Chemaitelly, Hiam; Malek, Joel A; Ahmed, Ayeda A; Mohamoud, Yasmin A; Younuskunju, Shameem; Ayoub, Houssein H; Al Kanaani, Zaina; Al Khal, Abdullatif; Al Kuwari, Einas; Butt, Adeel A; Coyle, Peter; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Latif, Ali Nizar; Shaik, Riyazuddin Mohammad; Abdul Rahim, Hanan F; Yassine, Hadi M; Al Kuwari, Mohamed G; Al Romaihi, Hamad Eid; Al-Thani, Mohamed H; Bertollini, Roberto.
Affiliation
  • Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Chemaitelly H; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar.
  • Malek JA; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.
  • Ahmed AA; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Mohamoud YA; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar.
  • Younuskunju S; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Ayoub HH; Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Al Kanaani Z; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Al Khal A; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Al Kuwari E; Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Butt AA; Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar.
  • Coyle P; Hamad Medical Corporation, Doha, Qatar.
  • Jeremijenko A; Hamad Medical Corporation, Doha, Qatar.
  • Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar.
  • Latif AN; Hamad Medical Corporation, Doha, Qatar.
  • Shaik RM; Hamad Medical Corporation, Doha, Qatar.
  • Abdul Rahim HF; Hamad Medical Corporation, Doha, Qatar.
  • Yassine HM; Hamad Medical Corporation, Doha, Qatar.
  • Al Kuwari MG; Hamad Medical Corporation, Doha, Qatar.
  • Al Romaihi HE; Hamad Medical Corporation, Doha, Qatar.
  • Al-Thani MH; College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
  • Bertollini R; Biomedical Research Center, Qatar University, Doha, Qatar.
Clin Infect Dis ; 73(7): e1830-e1840, 2021 10 05.
Article in En | MEDLINE | ID: mdl-33315061
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article